Pharmacogenomics Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Pharmacogenomics Market Analysis, Trends, Size, and Forecast.
Pharmacogenomics Market Industry Overview, Market Growth, Market Share,
Syndicate Report, and Business Research Reports – US and UK
Description
Global Pharmacogenomics Market: by Technology (Polymerase
Chain Reaction, Microarray, Sequencing, Electrophoresis, and Others), by
Application (Neurology, Oncology, Infectious Diseases, Pain Management, and
Others), by End-User (Hospitals & Clinics, Academic Institutes, Research
Institutes, and Others) and by Region – Global Industry Sizing, Growth, Trend,
Opportunity, and Forecast (2021–2027)
Get Free
Sample Copy @ https://www.marketstatsville.com/request-sample/pharmacogenomics-market
The pharmacogenomics market report covers a thorough
analysis of the market dynamics, business models, segmental/regional analysis,
and respective market shares and strategies adopted by the key market players
operating globally. It entails an in-depth analysis of the factors influencing
the global market and market statistics indicating region-wise and segment-wise
market share/growth analysis. The report's study will outlook one of the most
exhaustive market analyses, capturing all the pharmacogenomics industry
aspects.
Pharmacogenomics Industry Outlook
The pharmacogenomics market size was valued at USD 6.53
billion in 2020, which is expected to reach USD 9.47 billion by 2027,
registering a CAGR of 7.2% during the forecast period (2021-2027).
Pharmacogenomics is the study of pharmacology and genomics in human genes that
affect a person’s reaction to a particular drug. Pharmacogenomics aims to
ensure effective and safe medications with minimal side effects. Cardiovascular
diseases, AIDS, Alzheimer's disease, and cancer are diseases that can be
treated by pharmacogenomics.
Factors Affecting the Pharmacogenomics Industry over the
Forecast Period:
The rise in the geriatric population, increase in the
awareness among patients towards personalized therapy, growing adoption of
pharmacogenomics procedures by healthcare professionals, and high prevalence of
chronic diseases across the globe are the key factors expected to propel the
market growth of the pharmacogenomics
market over the forecast period.
Governments also provide financial aids, take initiatives,
craft rules & regulations and work towards the development & promotion
of pharmacogenomics which affects the market dynamics of pharmacogenomics.
However, the lack of skilled and highly trained healthcare
professionals and the high cost associated with the test may restrain the
growth of the pharmacogenomics market.
Impact of COVID-19 on Pharmacogenomics Market:
COVID-19 is a global public health disease that has affected
almost every industry. The outbreak of COVID-19 increased the demand for
pharmacogenomics. This creates many opportunities for new and small-scale
players to mark their presence in the regional market and offer low-cost prices
and high-quality products to the end-users. Therefore, with the outbreak of the
COVID-19, there is a significant surge in demand for pharmacogenomics that has
been seen across the globe, which has positively impacted the pharmacogenomics
market value in 2020 and subsequent years.
Get full
report in 24 hours in your inbox @ https://www.marketstatsville.com/pharmacogenomics-market
Scope of the Report
The report outlines the global pharmacogenomics market study
based on technology, application, and end user.
The pharmacogenomics market has been segmented based on
technology –
·
Polymerase Chain
Reaction
·
Microarray
·
Sequencing
·
Electrophoresis
·
Others
The pharmacogenomics market has been segmented based on
application –
·
Neurology
·
Oncology
·
Infectious Diseases
·
Pain Management
·
Others
The pharmacogenomics market has been segmented on the basis
of the end user –
·
Hospitals &
Clinics
·
Academic Institutes
·
Research Institutes
·
Others
Pharmacogenomics Market: Regional Outlook
Based on the region, the global pharmacogenomics market has
been segmented into five geographical regions, namely, North America, Asia
Pacific, Europe, South America, and the Middle East, and Africa. In 2019, North
America held the largest share in the pharmacogenomics market, followed by the
Asia Pacific and Europe due to the rising demand for personalized medicine and
technological advancement in the region. Moreover, Asia Pacific is expected to
project the highest CAGR globally over the forecast periods due to the rapidly
increasing aging population and growing R&D centers.
Key Global Pharmacogenomics Market Competitors Includes –
The pharmacogenomics market is highly fragmented, with a
large number of small players across the globe. The vital pharmacogenomics
market manufacturers operating in the global market are –
·
Abbott Laboratories
·
Bayer AG
·
Dickinson and
Company
·
Empire Genomics
·
F. Hoffmann-La
Roche Ltd.
·
Illumina Inc.
·
Johnson and Johnson
Services Inc.
·
Merck & Co.,
Inc.
Browse complete report@ https://www.marketstatsville.com/pharmacogenomics-market
About US:
Market Statsville Group (MSG) is
a full-service market research and business consulting platform of Statsville
Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market
research and strategy builder with the depth and breadth of solutions that
perfectly suit your every need. MSG provides solutions in a wide range of
industry verticals in the form of market sizing, analysis, and incisive
business insights. MSG experienced research analysts are proficient at digging
deep and providing a variety of customizable data that help you make decisions
with clarity, confidence, and impact. MSG has an entire repository of research
reports on more than 2,000 niche industries and more than 12,000 company
profiles
Contact Information:
Contact Us:
Market Statsville Group
416, East Standsberry Street, Perkins, Oklahoma 74059, USA
Email: sales@marketstatsville.com
USA: +1 (580) 205 2707 | India: +91 702 496 8807
Website: www.marketstatsville.com
Comments
Post a Comment